Patents Assigned to UNIVERSITY HOSPITAL OF NORTH NORWAY
  • ANTIBODIES AGAINST HPA-1A
    Publication number: 20170121422
    Abstract: The present invention provides an isolated antibody that specifically binds to HPA-1a. Also provided is a nucleic acid molecule that encodes the antibody, and compositions comprising the antibody. Also provided is a method of producing the antibody and methods and uses which employ the antibody. Also provided are therapeutic uses of the antibody, for example in the treatment or prophylaxis of fetal and neonatal alloimmune thrombocytopenia (FNAIT).
    Type: Application
    Filed: March 31, 2015
    Publication date: May 4, 2017
    Applicants: UNIVERSITETET I TROMSO - NORGES ARKTISKE UNIVERSIT ET, UNIVERSITY HOSPITAL OF NORTH NORWAY, NORINNOVA TECHNOLOGY TRANSFER AS
    Inventors: Terje MICHAELSEN, Oistein IHLE, Tor Brynjar STUGE, Anne HUSEBEKK, Heidi TILLER, Mariana EKSTEEN, Bjorn Ragnar SKOGEN